Vext Announces Revised Date for Q4 and Fiscal 2025 Financial Results Release
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today announced that further to its previous disclosure regarding the timing of its fourth quarter and full year 2025 financial results release and conference call, the Company now expects to release its financial results for the perio
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2026-04-21 4:30 PM EDT | VEXT Science, Inc.
Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart
Toronto, Ontario--(Newsfile Corp. - April 14, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, is pleased to announce that Cardiol's President and Chief Executive Officer, David Elsley, will participate in a live interview on X with
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2026-04-14 7:27 AM EDT | Cardiol Therapeutics Inc.
Akanda Corp. Announces Reverse Stock Split
Toronto, Ontario--(Newsfile Corp. - April 9, 2026) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that it expects to implement a 1-for-4.5 reverse stock split of the Company's common shares effective April 13, 2026. The reverse stock split was previously approved by the Company's shareholders on November 28, 2025 and Board of Directors on March 23, 2026 and will begin trading on an adjusted basis giving effect to the reverse stock split at the opening of market on
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-04-09 8:30 AM EDT | Akanda Corp
FloraWorks Announces TruCBN(TM) Readiness for the CMS Substance Access BEI Program with Full Clinical and Safety Substantiation
Portland, Oregon--(Newsfile Corp. - April 9, 2026) - FloraWorks today announced that TruCBN™ 50 mg softgels are available to healthcare organizations evaluating sleep-focused hemp products for the CMS Substance Access Beneficiary Engagement Incentive (BEI) program. In a published 1,020-person randomized, double-blind, placebo-controlled clinical trial, TruCBN™ 50 mg dose demonstrated statistically significant improvement in sleep quality. Real-world evidence has
Technology, Cannabis, Health, Cannabis Manufacturer
2026-04-09 8:00 AM EDT | FloraWorks
Akanda Adjourns Shareholder Meeting
Toronto, Ontario--(Newsfile Corp. - April 7, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today announced that on March 31, 2026, it convened and subsequently adjourned its Special Meeting of Shareholders (the "Meeting") without transacting any business due to the absence of a quorum. The Meeting has been adjourned and will be reconvened in person in Toronto, Ontario on Monday, April 27, 2026 at 10:00 a.m. (Eastern Time). The adjournment provides
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-04-07 8:30 AM EDT | Akanda Corp
Simply Solventless Provides Restructuring Update, Including Expected Timing, and Announces Management Change
Calgary, Alberta--(Newsfile Corp. - April 6, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC") is pleased to provide an update regarding the previously announced restructuring of Massive Hash Factory Ltd. ("MHF"), CannMart Inc. ("CannMart"), and ANC Inc. ("ANC") (and collectively with MHF and CannMart, the "CCAA Appl
Cannabis, Cannabis Cultivator, Cannabis Extractor, Cannabis Manufacturer
2026-04-06 6:00 AM EDT | Simply Solventless Concentrates Ltd.
Cardiol Therapeutics Announces Year-End 2025 Update on Operations
Initiated pivotal Phase III MAVERIC trial of CardiolRx™ in recurrent pericarditis and surpassed 50% patient enrollment, with full enrollment expected in Q2 2026. Reported positive Phase II ARCHER data showing CardiolRx™ significantly reduced left ventricular mass in patients with acute myocarditis; results published in ESC Heart Failure. Advanced CRD-38 program, a novel next generation drug intended for use in heart failure an
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2026-04-01 7:27 AM EDT | Cardiol Therapeutics Inc.
City View Investee Company ArkenYield Secures Circle Alliance Partnership
Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - City View Green Holdings Inc. (CSE: CVGR) (OTCID: CVGRF) (FSE: CVY0) (the "Company" or "City View"), announces that its investee company ArkenYield, a builder of stablecoin liquidity and yield infrastructure, has joined the Circle Alliance Program, positioning the Company among a select group of infrastructure providers and fintech platforms building directly with USDC. This milestone places ArkenYield alongside leading participants i
Food / Beverages, Cannabis, Cannabis Extractor, Cannabis Manufacturer
2026-04-01 6:30 AM EDT | City View Green Holdings Inc.
Captiva Verde Welcomes Josh F.W. Cook to the Advisory Board
Jacksonville, Florida--(Newsfile Corp. - March 30, 2026) - Captiva Verde Corp. (CSE: PWR) (OTC Pink: CPIVF) (the "Company or Captiva") announces the appointment of Josh F.W. Cook to the Advisory Board. Josh F.W. Cook is a seasoned government executive and communications consultant with over 30 years of experience solving complex political and natural resource conflicts in California, Arizona, and Nevada. Josh most recently served as EPA Administrator for R
Agriculture, Cannabis, Cannabis Manufacturer
2026-03-30 9:00 AM EDT | Captiva Verde Wellness Corp.
Vext Science Announces Strategic Optimization of Arizona Operations and Plans for Ohio Cultivation Expansion
Strategic closure and planned sale of Eloy cultivation facility expected to improve Arizona profitability and enhance free cash flow. Proceeds from the sale to facilitate debt reduction, with key equipment redeployed to the Ohio market, saving approximately $2 million in capital expenditures to support Vext's build-out in the State. Plans to seek approval to expand Jackson cultivation to support a growing retail footprint a
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2026-03-30 7:30 AM EDT | VEXT Science, Inc.
Akanda Corp. Driving Recurring Revenue Growth: $2 Million Cash Flow Secured Through Fiber Acquisition
Toronto, Ontario--(Newsfile Corp. - March 26, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda") and its wholly owned subsidiary, First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, are pleased to announce an expansion of its dark fiber network with the addition of approximately 200 kilometres, increasing total network coverage to approximately 900 kilometres across Central Mexico. This milestone is expected to material
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-03-26 8:30 AM EDT | Akanda Corp